RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis
Europe - FRA:RHK - DE0007042301 - Common Stock
11.7 EUR
+0.1 (+0.86%)
We assign a fundamental rating of 4 out of 10 to RHK. RHK was compared to 35 industry peers in the Health Care Providers & Services industry. RHK has an average financial health and profitability rating. RHK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
RHK had positive earnings in the past year.
RHK had a positive operating cash flow in the past year.
In the past 5 years RHK has always been profitable.
Each year in the past 5 years RHK had a positive operating cash flow.
1.2 Ratios
RHK has a Return On Assets of 2.02%. This is in the lower half of the industry: RHK underperforms 62.50% of its industry peers.
With a Return On Equity value of 2.90%, RHK is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
The Return On Invested Capital of RHK (2.67%) is worse than 71.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RHK is below the industry average of 7.16%.
The last Return On Invested Capital (2.67%) for RHK is above the 3 year average (2.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| ROIC | 2.67% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
1.3 Margins
RHK has a Profit Margin (2.28%) which is in line with its industry peers.
RHK's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.86%, RHK is doing worse than 65.63% of the companies in the same industry.
RHK's Operating Margin has declined in the last couple of years.
RHK has a Gross Margin of 66.81%. This is in the better half of the industry: RHK outperforms 71.88% of its industry peers.
In the last couple of years the Gross Margin of RHK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.86% | ||
| PM (TTM) | 2.28% | ||
| GM | 66.81% |
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
RHK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for RHK remains at a similar level compared to 1 year ago.
Compared to 5 years ago, RHK has about the same amount of shares outstanding.
RHK has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.98 indicates that RHK is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of RHK (2.98) is better than 78.13% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that RHK is not too dependend on debt financing.
RHK has a Debt to Equity ratio of 0.09. This is amongst the best in the industry. RHK outperforms 96.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.98 |
ROIC/WACC0.42
WACC6.42%
2.3 Liquidity
A Current Ratio of 2.28 indicates that RHK has no problem at all paying its short term obligations.
RHK has a better Current ratio (2.28) than 96.88% of its industry peers.
A Quick Ratio of 2.19 indicates that RHK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.19, RHK belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
The earnings per share for RHK have decreased strongly by -19.59% in the last year.
The Earnings Per Share has been growing slightly by 0.03% on average over the past years.
The Revenue has grown by 9.41% in the past year. This is quite good.
The Revenue has been growing slightly by 4.12% on average over the past years.
EPS 1Y (TTM)-19.59%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-28.57%
Revenue 1Y (TTM)9.41%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%6.64%
3.2 Future
The Earnings Per Share is expected to grow by 11.47% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.84% on average over the next years.
EPS Next Y9.14%
EPS Next 2Y10.96%
EPS Next 3Y11.09%
EPS Next 5Y11.47%
Revenue Next Year5.98%
Revenue Next 2Y4.97%
Revenue Next 3Y6.5%
Revenue Next 5Y5.84%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.89, which indicates a rather expensive current valuation of RHK.
RHK's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.40, RHK is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.18, the valuation of RHK can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RHK is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of RHK to the average of the S&P500 Index (22.94), we can say RHK is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.89 | ||
| Fwd PE | 15.18 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -0.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.29
PEG (5Y)614.38
EPS Next 2Y10.96%
EPS Next 3Y11.09%
5. Dividend
5.1 Amount
RHK has a yearly dividend return of 0.86%, which is pretty low.
Compared to an average industry Dividend Yield of 2.25, RHK has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, RHK's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.86% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
17.78% of the earnings are spent on dividend by RHK. This is a low number and sustainable payout ratio.
DP17.78%
EPS Next 2Y10.96%
EPS Next 3Y11.09%
FRA:RHK (10/17/2025, 7:00:00 PM)
11.7
+0.1 (+0.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.55%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap783.43M
Analysts74.29
Price Target14.45 (23.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.86% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP17.78%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.89 | ||
| Fwd PE | 15.18 | ||
| P/S | 0.47 | ||
| P/FCF | N/A | ||
| P/OCF | 12.7 | ||
| P/B | 0.6 | ||
| P/tB | 0.7 | ||
| EV/EBITDA | -0.41 |
EPS(TTM)0.56
EY4.79%
EPS(NY)0.77
Fwd EY6.59%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.92
OCFY7.88%
SpS24.7
BVpS19.41
TBVpS16.81
PEG (NY)2.29
PEG (5Y)614.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| ROCE | 3.25% | ||
| ROIC | 2.67% | ||
| ROICexc | 4.45% | ||
| ROICexgc | 5.55% | ||
| OM | 2.86% | ||
| PM (TTM) | 2.28% | ||
| GM | 66.81% | ||
| FCFM | N/A |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
ROICexc(3y)3.1%
ROICexc(5y)2.62%
ROICexgc(3y)3.7%
ROICexgc(5y)3.13%
ROCE(3y)2.85%
ROCE(5y)2.44%
ROICexcg growth 3Y17.7%
ROICexcg growth 5Y-1.56%
ROICexc growth 3Y17.75%
ROICexc growth 5Y-1.75%
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
F-Score6
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.07 | ||
| Cap/Depr | 112.99% | ||
| Cap/Sales | 4.21% | ||
| Interest Coverage | 14.78 | ||
| Cash Conversion | 56.66% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.19 | ||
| Altman-Z | 2.98 |
F-Score6
WACC6.42%
ROIC/WACC0.42
Cap/Depr(3y)97.27%
Cap/Depr(5y)108.32%
Cap/Sales(3y)4.24%
Cap/Sales(5y)5.08%
Profit Quality(3y)86.55%
Profit Quality(5y)290.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.59%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%-28.57%
EPS Next Y9.14%
EPS Next 2Y10.96%
EPS Next 3Y11.09%
EPS Next 5Y11.47%
Revenue 1Y (TTM)9.41%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%6.64%
Revenue Next Year5.98%
Revenue Next 2Y4.97%
Revenue Next 3Y6.5%
Revenue Next 5Y5.84%
EBIT growth 1Y2.05%
EBIT growth 3Y16.29%
EBIT growth 5Y-3.2%
EBIT Next Year147.27%
EBIT Next 3Y44.19%
EBIT Next 5Y27.85%
FCF growth 1Y26.17%
FCF growth 3Y42.66%
FCF growth 5YN/A
OCF growth 1Y42.49%
OCF growth 3Y9.38%
OCF growth 5Y21.95%